Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targetsNicholas C. Turner, Jorge S. Reis‐Filho, Rachel Sharpe et al.|Oncogene|2010Cited by 416
Integrative Molecular Profiling of Triple Negative Breast Cancers Identifies Potential Therapeutic Targets Including Amplifications of FGFR2.Nicholas C. Turner, Jorge S. Reis‐Filho, Maryou Lambros et al.|Cancer Research|2009Cited by 1